Thyromental Height Test as a Predictor of Difficult Airway:

February 10, 2020 updated by: Abeer Ahmed, MD, Cairo University

The Validity of the Thyromental Height Test as a Predictor of the Difficult Airway: A Prospective Comparative Study With Interincisor Distance, Thyromental Distance, Sternomental Distance & Modified Mallampati Test

Anesthesia is increasingly safe. Major complications of airway management are no more common but still the most life-threatening condition amongst anesthesia practice and even medicine. Thyromental height test (TMHT) is an objective measure of the height between the anterior borders of the mentum and thyroid cartilage, measured while the patient is lying supine with the mouth closed. This study was designed to assess the validity of the TMHT as a single objective predictor for difficult laryngoscopy and to be compared to other objective measures.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

612

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients, aged from 18-60 years old, with ASA physical status I & II who will undergo elective surgical procedures under general anesthesia using endotracheal intubation using conventional laryngoscopy.

Description

Inclusion Criteria:

  • ASA physical status I & II
  • Scheduled for elective surgical procedures under general anesthesia using endotracheal with conventional laryngoscopy

Exclusion Criteria:

  • Patients with a body mass index >35 kg/m2.
  • Patients with neuromuscular disorders, craniofacial abnormalities, and abnormal dentition.
  • Patients with airway diseases e.g cancer larynx or tongue, uncooperative patients, those who will need awake intubation and patients who will undergo emergency operations.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
validity of the TMHT in prediction of difficult airway in patients undergoing general anesthesia for elective surgeries using area under ROC curve for the TMHT.
Time Frame: baseline (before induction of general anesthesia)
baseline (before induction of general anesthesia)
Validity of TMHT in comparison with that of Modified Mallampati test (MMT) in prediction of difficult airway by comparing area under ROC curve for both tests.
Time Frame: baseline (before induction of general anesthesia)
baseline (before induction of general anesthesia)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 20, 2020

Primary Completion (Anticipated)

August 20, 2020

Study Completion (Anticipated)

October 20, 2020

Study Registration Dates

First Submitted

February 3, 2020

First Submitted That Met QC Criteria

February 10, 2020

First Posted (Actual)

February 11, 2020

Study Record Updates

Last Update Posted (Actual)

February 11, 2020

Last Update Submitted That Met QC Criteria

February 10, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • MD-246-2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Difficult Intubation

Clinical Trials on Thyromental height test

Subscribe